February 2023 ZOHU Call
- One Health and Wildlife: Current Outbreak of Highly Pathogenic Avian Influenza in North America
- Environmental fungicides and the development of antifungal drug-resistant mold infections in humans and animals
- Knowledge, Attitudes, and Practices of SARS-CoV-2 in Animals Among Veterinarians in Los Angeles County
Date: Wednesday, February 1, 2023
Time: 2:00-3:00 pm (Eastern Time)
Web-on-Demand: A captioned video recording has been posted.
See and hear the presentations and ask questions online.
Please use the link below and enter the passcode: zohu@feb1
https://cdc.zoomgov.com/j/1606508274?pwd=YzFJKys5L0M3WlFwS1ZMRjdaYTlCUT09
Listen only by phone
US: +1 669 254 5252 or +1 646 828 7666 or +1 646 964 1167 or +1 415 449 4000 or +1 551 285 1373 or +1 669 216 1590
Passcode: 476333626
International numbers available: https://cdc.zoomgov.com/u/actsYwS2V6
Course Access Code: ZOHUwebcast
Webcast: WC4565(SC)-020123
Origination Date: February 1, 2023
Expiration Date: March 6, 2023
Web-on-Demand: WD4565(SC)-020123
Origination Date: March 7, 2023
Expiration Date: March 7, 2025
Presentations
One Health and Wildlife: Current Outbreak of Highly Pathogenic Avian Influenza in North America
Nicole Nemeth, DVM, PhD, Dipl. ACVP
Associate Professor
Dept. of Pathology and Southeastern Cooperative Wildlife Disease Study
University of Georgia
nmnemeth@uga.edu
Environmental fungicides and the development of antifungal drug-resistant mold infections in humans and animals
Jeremy Gold, MD, MS
Medical Officer
Division of Foodborne, Waterborne, and Environmental Diseases
Centers for Disease Control and Prevention
leo3@cdc.gov
Knowledge, Attitudes, and Practices of SARS-CoV-2 in Animals Among Veterinarians in Los Angeles County
Allison Joyce, MSc
Epidemiology Analyst
Health Veterinary Public Health Program
Los Angeles County Department of Public Health
ajoyce@ph.lacounty.gov
Resources
One Health and Wildlife: Current Outbreak of Highly Pathogenic Avian Influenza in North America
- USDA Highly Pathogenic Avian Influenza (HPAI)
- USDA 2022-2023 Detections of Highly Pathogenic Avian Influenza in Wild Birds
- USDA 2022 Confirmations of Highly Pathogenic Avian Influenza in Commercial and Backyard Flocks
- Response to detections of avian influenza in Canada
- Gov. of Canada, Fact sheet – Avian Influenza
- CDC Bird Flu Virus Infections in Humans
- CDC Avian Influenza Updates
Environmental fungicides and the development of antifungal drug-resistant mold infections in humans and animals
- Emerging Fungal Infections: from the Fields to the Clinic, Resistant Aspergillus fumigatus and Dermatophyte Species: a One Health Perspective on an Urgent Public Health Problem
- Multidrug-Resistant Aspergillus fumigatus Carrying Mutations Linked to Environmental Fungicide Exposure — Three States, 2010–2017
- Fatal Fungicide-Associated Triazole-Resistant Aspergillus fumigatus Infection, Pennsylvania, USA – Volume 28, Number 9—September 2022
- CDC AR Lab Network requests isolates of Aspergillus fumigatus [PDF – 1 page]
Knowledge, Attitudes, and Practices of SARS-CoV-2 in Animals Among Veterinarians in Los Angeles County
Overall series objectives:
- Identify an implication for human, animal, and environmental health.
- Identify a One Health approach strategy for prevention of public health threats.
- Identify a One Health approach strategy for detection of public health threats.
- Identify a One Health approach strategy for responding to public health threats.
- List two ways to improve collaborative practice across the public healthcare team.
Disclosures:
In compliance with continuing education requirements, all presenters must disclose any financial or other associations with the manufacturers of commercial products, suppliers of commercial services, or commercial supporters as well as any use of unlabeled product(s) or product(s) under investigational use.
CDC, our planners, presenters, and their spouses/partners wish to disclose they have no financial interests or other relationships with the manufacturers of commercial products, suppliers of commercial services, or commercial supporters.
The planning committee reviewed content to ensure there is no bias.
The presentations will not include any discussion of the unlabeled use of a product or a product under investigational use.
CDC did not accept commercial support for this activity.
